Baucus Hearing Statement: ''Medicaid Waste, Fraud and Abuse: Threatening the Health Care Safety Net''
Statement of U.S. Senator Max Baucus
United States Senate Finance Committee Hearing
“Medicaid Waste, Fraud and Abuse: Threatening the Health Care Safety Net”
As the title of today’s hearing shows, Medicaid is a critical part of our health care safety
net. More than 53 million Americans depend on Medicaid for their health care. Medicaid covers
2 in 5 births, 1 in 4 children, and 40 percent of all long-term care services. Medicaid protects the
most vulnerable among us.
We must ensure that Medicaid is there for those who need it. And that means ensuring
that Medicaid’s dollars are spent appropriately.
Over the next 2 days, witnesses will tell us that — sometimes — Medicaid’s dollars are
not spent appropriately. Whether through inflated pharmacy payments, improper asset transfers,
or questionable state financing methods, Medicaid money is sometimes misspent.
And as rising health-care costs strain federal and state budgets, we can’t afford to waste
these precious resources. When Medicaid funds are misspent, Congress should act.
Congress has done so in the past, by reining in excessive Disproportionate Share Hospital
(DSH) payments in the 1990s. And in recent years, by cracking down on upper payment limit
schemes.
I am not suggesting that our work is done. We should not overpay for prescription drugs
under Medicaid. And we should not encourage the creation of a cottage industry where
consultants are hired by states to maximize federal Medicaid dollars.
But let’s not assume that all growth in Medicaid spending is the result of fraudulent
activity. Let’s remember that Medicaid spending is growing for many legitimate reasons.
First, increased enrollment. During the last recession, 7.5 million Americans had to turn
to Medicaid for their health care. That’s 7.5 million people who would probably be uninsured
without Medicaid. When times are tough, Medicaid meets the need. That is what it’s supposed
to do.
Second, Medicaid is growing due to the rising cost of long-term care. And as America
ages, the need for long-term care will grow.
Third, Medicaid is subject to plain old health care inflation — just like every other
insurance plan in this country.
And to be fair, Medicaid growth is actually lower on a per-person basis than many other
forms of insurance. Between 2000 and 2003, private insurance costs grew over 12 percent per
person. For Medicaid, the growth was just 6.9 percent.
But Medicaid has room for improvement – just like other forms of health insurance. We
need to reward high-quality care. Move away from the idea that more care is necessarily better
care. And promote evidence-based medicine.
This week Senator Grassley and I plan to introduce a bill to improve quality and reward
high performance in Medicare. And I look forward to working with the Chairma n to extend
those principles to Medicaid.
We also need more transparency and consistency in Medicaid. This transparency and
consistency should extend to state financing arrangements, as well as to the administration’s use
of section 1115 waiver authority.
States need to know the rules of financing arrangements up front. And they must have
confidence that Centers for Medicare and Medicaid (CMS) will judge these arrangements by the
same, consistent standards. States lack that confidence now.
For example, in 2001 CMS made an effort to close upper payment limit loopholes. But
according to the Government Accountability Office (GAO), while CMS was closing loopholes in
some states, the agency was allowing other states to engage in the very schemes it was trying to
shut down. And at a substantial cost to taxpayers.
In 2003, CMS, implemented a new policy on intergovernmental transfers. CMS required
states submitting changes to their Medicaid programs to answer a list of questions.
Based on their answers, states were told whether or not they were violating the law. But
states had no way of knowing whether CMS was applying different rules to different states.
That brings me to waiver authority. I’ve said it before, and I’ll say it again: CMS has
waiver authority for experimentation in Medicaid — not wholesale change. Waiver authority
was not designed to create a closed-door process in which stakeholders find out about a waiver
only after the ink is dry.
Mr. Chairman, I welcome the opportunity to ensure that Medicaid dollars are spent
wisely. I applaud your long-standing commitment to that end.
But the administration must do its part as well. It must work cooperatively with states to
improve Medicaid. It must play a more active role in ensuring that Medicaid is a prudent
purchaser of health care. And it must enforce the law consistently, fairly and uniformly.
Thank you, Mr. Chairman. I thank our distinguished witnesses for being here today, and
I look forward to their testimony.
# # #
Next Article Previous Article